SP1 and glioblastoma: In addition, Sp1 overexpression exacerbates the prognosis of GBM patients as a result of enhanced proliferation, invasion and the reduced sensitivity of cells to chemotherapy.19 In spite of these findings, the interaction of Sp1 with DNA methylation in GBM has not been clearly defined.